| PLCG1 |
PLCG1, PLC1: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-1 |
FLT3 |
FLT3, STK1: FL cytokine receptor precursor |
0.502 |
Evidence |
|
| PLCG1 |
PLCG1, PLC1: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-1 |
EPHA7 |
EPHA7, EHK3, HEK11: Ephrin type-A receptor 7 precursor |
0.502 |
Evidence |
|
| PLCG1 |
PLCG1, PLC1: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-1 |
TEK |
TEK, TIE2: Angiopoietin-1 receptor precursor |
0.502 |
Evidence |
|
| GNAT2 |
GNAT2, GNATC: Guanine nucleotide-binding protein G(t), alpha-2 subunit |
RGS19 |
RGS19, GAIP, GNAI3IP: Regulator of G-protein signaling 19 |
0.502 |
Evidence |
|
| FER |
FER, TYK3: Proto-oncogene tyrosine-protein kinase FER |
TEK |
TEK, TIE2: Angiopoietin-1 receptor precursor |
0.502 |
Evidence |
|
| PDGFRA |
PDGFRA: Alpha-type platelet-derived growth factor receptor precursor |
SH2D2A |
SH2D2A, SCAP, TSAD, VRAP: SH2 domain-containing protein 2A |
0.502 |
Evidence |
|
| PDGFRA |
PDGFRA: Alpha-type platelet-derived growth factor receptor precursor |
TXK |
TXK, PTK4: Tyrosine-protein kinase TXK |
0.502 |
Evidence |
|
| IFNGR1 |
IFNGR1: Interferon-gamma receptor alpha chain precursor |
IL22 |
IL22, ILTIF, UNQ3099/PRO10096: Interleukin-22 precursor |
0.502 |
Evidence |
|
| CCL5 |
CCL5, D17S136E, SCYA5: Small-inducible cytokine A5 precursor |
AGTR1 |
AGTR1, AGTR1A, AGTR1B, AT2R1, AT2R1B: Type-1 angiotensin II receptor |
0.502 |
Evidence |
|
| CCL5 |
CCL5, D17S136E, SCYA5: Small-inducible cytokine A5 precursor |
DRD1 |
DRD1: D(1A) dopamine receptor |
0.502 |
Evidence |
|
| CCL2 |
CCL2, MCP1, SCYA2: Small-inducible cytokine A2 precursor |
F2RL3 |
F2RL3, PAR4: Proteinase-activated receptor 4 precursor |
0.502 |
Evidence |
|
| CCL2 |
CCL2, MCP1, SCYA2: Small-inducible cytokine A2 precursor |
LTB4R |
LTB4R, BLT, BLT1, BLTR, CMKRL1, GPR16, P2RY7: Leukotriene B4 receptor 1 |
0.502 |
Evidence |
|
| CCL2 |
CCL2, MCP1, SCYA2: Small-inducible cytokine A2 precursor |
TACR2 |
TACR2, NK2R, NKNAR, TAC2R: Substance-K receptor |
0.502 |
Evidence |
|
| CCL4 |
CCL4, CCL4L, LAG1, MIP1B, SCYA4, SCYA4L: Small-inducible cytokine A4 precursor |
F2RL1 |
F2RL1, GPR11, PAR2: Proteinase-activated receptor 2 precursor |
0.502 |
Evidence |
|
| CCL4 |
CCL4, CCL4L, LAG1, MIP1B, SCYA4, SCYA4L: Small-inducible cytokine A4 precursor |
AGTR1 |
AGTR1, AGTR1A, AGTR1B, AT2R1, AT2R1B: Type-1 angiotensin II receptor |
0.502 |
Evidence |
|
| CCL4 |
CCL4, CCL4L, LAG1, MIP1B, SCYA4, SCYA4L: Small-inducible cytokine A4 precursor |
TACR2 |
TACR2, NK2R, NKNAR, TAC2R: Substance-K receptor |
0.502 |
Evidence |
|
| F5 |
F5: Coagulation factor V precursor |
EPHA4 |
EPHA4, HEK8, SEK, TYRO1: Ephrin type-A receptor 4 precursor |
0.502 |
Evidence |
|
| KIT |
KIT: Mast/stem cell growth factor receptor precursor |
PTK6 |
PTK6, BRK: Tyrosine-protein kinase 6 |
0.502 |
Evidence |
|
| IL8 |
IL8: Interleukin-8 precursor |
P2RY4 |
P2RY4, NRU: P2Y purinoceptor 4 |
0.502 |
Evidence |
|
| IL8 |
IL8: Interleukin-8 precursor |
AGTR1 |
AGTR1, AGTR1A, AGTR1B, AT2R1, AT2R1B: Type-1 angiotensin II receptor |
0.502 |
Evidence |
|
| IL8 |
IL8: Interleukin-8 precursor |
HTR2C |
HTR2C, HTR1C: 5-hydroxytryptamine receptor 2C |
0.502 |
Evidence |
|
| IL8 |
IL8: Interleukin-8 precursor |
EDG1 |
EDG1: Sphingosine 1-phosphate receptor Edg-1 |
0.502 |
Evidence |
|
| IL8 |
IL8: Interleukin-8 precursor |
TACR2 |
TACR2, NK2R, NKNAR, TAC2R: Substance-K receptor |
0.502 |
Evidence |
|
| FGR |
FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR |
MERTK |
MERTK, MER: Proto-oncogene tyrosine-protein kinase MER precursor |
0.502 |
Evidence |
|
| FGR |
FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR |
TEK |
TEK, TIE2: Angiopoietin-1 receptor precursor |
0.502 |
Evidence |
|